Sánchez Muñoz-Torrero J F, Yñiguez T R, García-Onieva E, Pascua F J, Crespo L, Bacaicoa A, Martín C
Servicio de Medicina Interna, Clínica del Complejo Hospitalario de Cáceres.
Rev Clin Esp. 1995 Jul;195(7):468-72.
Nocardia usually infects immunosuppressed patients, particularly with cellular immunity deficiency. Nevertheless, despite severe immunosuppression in patients infected with HIV, nocardiosis is rare among these patients. We report here two cases of nocardiosis in patients with HIV infection and review spanish literature up to 1993, with an analysis of the characteristics of this infection in our country.
The two patients consumed drugs parenterally and Nocardia organism were recovered in blood cultures after 48 hours of inoculation in standard culture media. The source of the infection was cutaneous in one patient, over an area of venipuncture, and pulmonary in the other patient. Previously, eleven cases of nocardiosis had been reported in the spanish literature in patients infected with HIV. Eighty-four percent were males, and all of them consumed drugs parenterally and displayed a severe cellular immunodepression; the total CD4 lymphocyte count was lower than 100/mm3 in patients when this finding was available (6/13). At diagnosis only one patient received prophylaxis against other type of infection with antibiotics theoretically effective against Nocardia at diagnosis. The Nocardia species recovered more frequently was asteroides (77%) and the most common location was the skin (54%). Treatments more frequently employed were sulfametoxazole-trimethoprim (45%) and sulfadiazine (36%), with a good response except in those with cerebral involvement.
Nocardiosis in patients with HIV infection is rare in Spain. In contrast with other geographical areas skin involvement was the more common form of infection. Prophylaxis with sulfametoxazole-trimethoprim against other infections could be responsible for a lower than expected incidence among this type of patients.
诺卡菌通常感染免疫抑制患者,尤其是细胞免疫缺陷者。然而,尽管感染人类免疫缺陷病毒(HIV)的患者存在严重免疫抑制,但诺卡菌病在这些患者中却很罕见。我们在此报告两例HIV感染患者的诺卡菌病病例,并回顾截至1993年的西班牙文献,分析我国这种感染的特征。
两名患者均接受胃肠外给药,将诺卡菌接种于标准培养基中48小时后,血培养中分离出该菌。其中一名患者的感染源为皮肤,位于静脉穿刺部位,另一名患者的感染源为肺部。此前,西班牙文献已报道11例HIV感染患者的诺卡菌病。84%为男性,所有患者均接受胃肠外给药且存在严重细胞免疫抑制;有此发现时(6/13),患者的总CD4淋巴细胞计数低于100/mm³。诊断时只有一名患者接受了理论上对诺卡菌有效的抗生素预防其他类型感染。最常分离出的诺卡菌种为星型诺卡菌(77%),最常见的感染部位是皮肤(54%)。最常使用的治疗药物是磺胺甲恶唑-甲氧苄啶(45%)和磺胺嘧啶(36%),除脑部受累患者外,疗效良好。
在西班牙,HIV感染患者中的诺卡菌病很罕见。与其他地区不同,皮肤受累是更常见的感染形式。使用磺胺甲恶唑-甲氧苄啶预防其他感染可能导致这类患者的发病率低于预期。